Aflibercept in AMD: no proof of added benefit
Manufacturer's dossier did not contain any usable data for the comparison with ranibizumab The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Manufacturer's dossier did not contain any usable data for the comparison with ranibizumab The drug aflibercept (trade name: Eylea) has been approved in Germany since November 2012 for the treatment…
You must be logged in to post a comment.